Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

11,350articles mentioning institutions

22,378institution mentions

9,137distinct institutions extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted institutions

Showing 6,181–6,240 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.

National Ambulatory Care Reporting System1 National Audit Project 31 National Audit of Cardiac Rehabilitation1 National Autonomous University of Mexico1 National Bioproducts Institute of South Africa1 National Breast Cancer Screening Program in Taiwan1 National Cancer Center1 National Cancer Center Institutional Review Board1 National Cancer Center in China1 National Cancer Control Programme1 National Cancer Grid1 National Cancer Institute CPTAC1 National Cancer Institute Sri Lanka1 National Cardiovascular Center Harapan Kita Hospital1 National Center for Biotechnology Information1 National Center for Cancer Care and Research1 National Center for Catastrophic Sport Injury Research1 National Center for Education Statistics1 National Center for Geriatrics and Gerontology, Japan1 National Center for Global Health and Medicine1 National Center for Neurosurgery1 National Center for Respiratory Medicine1 National Centre for Chronic and Non-communicable Disease Control and Prevention1 National Centre for Hydrology and Meteorology1 National Centre for Orthopaedics1 National Centre for Public Health and Pharmacy1 National Centre for Social Research1 National Child Mortality Database1 National Child Safeguarding Practice Review Panel1 National Children’s Hospital1 National Children’s Medical Centre1 National Clinical Research Center1 National Collegiate Athletic Association1 National Congenital Heart Disease Audit1 National Database of Health Insurance Claims of Japan1 National Dental Epidemiology Programme1 National Electronic Injury Surveillance System All Injury Programme1 National Electronic Injury Surveillance System–All Injury Program1 National Family Health Surveys1 National Free Preconception Checkups Project1 National GTD Centre1 National Genomic Research Library1 National Genomic Test Directory1 National Genomics Infrastructure in Stockholm1 National Health Information Database of South Korea1 National Health Insurance Service -Senior database1 National Health Sciences Research Committee in Malawi1 National Health Service (NHS) Research and Development Departments1 National Health Service Highland1 National Health Service Teaching Hospital1 National Health Service in England1 National Health Statistics1 National Health Survey1 National Health Surveys1 National Health and Ageing Trends Study1 National Health and Medical Research Council1 National Healthcare Group’s Domain Specific Review Board1 National Heart Centre Singapore1 National Heart Failure Registry1 National Heart and Lung Institute1

View all 9,137 institutions on one page

Articles mentioning institutions

11,350 articles · page 312 of 946

521 Correlative analysis of a phase I study of autologous activated NK Cells ± rhIL-15 in children and young adults with refractory solid tumors

jitc · abstract · 2025-11-04 · 2 matching annotations

93.7%

National Cancer Institute NCI rhIL-15 solid tumors relapsed/refractory solid tumors NK cell immunotherapies cyclophosphamide

…his study was approved by the Institutional Review Board of the National Cancer Institute (NCI) at the NIH, approval number 13-C-0152, and was conducted …

522 A clinical study on iNeo-Vac-P01: a personalized neoantigen immunotherapy for postoperative recurrence prevention in pancreatic cancer

jitc · abstract · 2025-11-04 · 2 matching annotations

95.3%

Zhejiang Provincial People’s Hospital iNeo-Vac-P01 pancreatic ductal adenocarcinoma (PDAC)

…n-label, single-arm clinical trial ( NCT04810910), conducted at Zhejiang Provincial People’s Hospital, enrolled PDAC patients who initiated treatment with iNeo-Vac-P…

536 Phase 1 trial of tumor-infiltrating lymphocyte (TIL) therapy in recurrent glioblastoma: A single-center experience using cells derived from primary surgical specimens

jitc · abstract · 2025-11-04 · 2 matching annotations

97.5%

Second Affiliated Hospital of Soochow University The Second Affiliated Hospital of Soochow University cyclophosphamide hydroxychloroquine Glioblastoma left frontal lobe glioblastoma sintilimab Innovent GB

… open-label, nonrandomized clinical trial ( NCT04943913) at the Second Affiliated Hospital of Soochow University to evaluate the safety and efficacy of TIL therapy in recurrent…

537 Targeting diffuse intrinsic pontine glioma with IL-7Rα-enhanced B7-H3 (CMD03) chimeric antigen receptor T cell: preliminary results from phase 1 clinical trial

jitc · abstract · 2025-11-04 · 2 matching annotations

97.0%

Chulalongkorn University Cancer Immunol Immunother dexamethasone CMD03 anakinra B7-H3 Diffuse intrinsic pontine glioma (DIPG)B7-H3-targeting DIPG

…DIPG ( NCT06221553). Approval was granted by the IRB committee, Chulalongkorn University (COA#1647/2024). Dose levels include 1×107, 3×107, and 1×108 CA…

54 Development and characterization of cytokine-based classifiers to predict response to immunotherapy using an ex vivo live tumor fragment platform

jitc · abstract · 2025-11-04 · 2 matching annotations

79.9%

Voabil et al.NCT05478538 αPD-1 αPD-L1 αCTLA-4

…ovide external validation of a weighted classifier published by Voabil et al.1 for predicting response to PD-1 blockade. Additionally, we tra…

552 Feasibility and tolerability of a CD4 re-directed chimeric antigen receptor T cell therapy (CD4CAR) in hematological malignancies: Initial results from multi-institutional first-in-human (FIH) trials

jitc · abstract · 2025-11-04 · 2 matching annotations

98.3%

Indiana University University of Miami FDA AML bendamustine acute myeloid leukemias chronic myelomonocytic leukemia fludarabine/cyclophosphamide TCM venetoclax+3 more

…CT06197672Ethics Approval The study obtained ethics approval by Indiana University and University of Miami IRB and participants gave informed cons…

553 A phase I clinical trial of allogeneic NKT cells expressing a CD19-specific CAR in patients with relapsed or refractory B cell malignancies: an interim analysis

jitc · abstract · 2025-11-04 · 2 matching annotations

94.1%

Baylor College of Medicine BCM graft-versus-host disease B cell malignancies IL-15 ALL-1 NHL-2 ALL-3

…al This study was approved by the Institutional Review Board at Baylor College of Medicine (BCM; H-44526).…

556 Transposon-based BAFF CAR-T cells (LMY-920) for treatment of non-hodgkin lymphoma (NHL), chronic lymphocytic lymphoma (CLL) and multiple myeloma (MM)

jitc · abstract · 2025-11-04 · 2 matching annotations

92.2%

Case Comprehensive Cancer Center Cleveland Clinic’s Institutional Review Board fludarabine lymphoma myeloma cyclophosphamide LMY-920 systemic lupus erythematosus MM DLBCL+2 more

…06916767Ethics Approval The study obtained ethics approval from Case Comprehensive Cancer Center, Cleveland Clinic’s Institutional Review Board (24-424/MOD01553…

560 Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in bilateral lung transplantation: case series

jitc · abstract · 2025-11-04 · 2 matching annotations

97.1%

Northwestern Memorial Hospital Northwestern University durvalumab atezolizumab bilateral non-small cell lung cancer toripalimab nivolumab COPD cemiplimab colorectal cancer+4 more

…o underwent bilateral orthotopic lung transplantation (BOLT) at Northwestern Memorial Hospital (Sep 2021-May 2025) after at least one cycle of ICI therapy. Pa…

580 Phase 1 study of mitotic checkpoint inhibitor BAL0891 in combination with tislelizumab (anti-PD-1 antibody) in patients with advanced solid tumors

jitc · abstract · 2025-11-04 · 2 matching annotations

86.5%

Cancer Res 2025 BAL0891 tislelizumab triple-negative breast cancer TTK-CS-101

…2164. https://doi.org/10.1158/1538-7445.AM2025-2164Wang, et al. Cancer Res 2025;85(8_Supplement_1):2169. https://doi.org/10.1158/1538-7445.AM20…

582 First-in-human phase 1/2 study of the integrin αvβ8-blocking antibody CRB-601 in patients with solid tumors

jitc · abstract · 2025-11-04 · 2 matching annotations

80.1%

Cedars-Sinai Medical Center Stephenson Cancer Center CRB-601 ovarian cancer head and neck squamous cell carcinoma melanoma

…University Hospital Cleveland University Hospitals IRB 20241088 Cedars-Sinai Medical Center Cedars-Sinai Office of Research Compliance and Quality Improvem…

583 Intrathecal PD-1 inhibitor combined with pemetrexed for leptomeningeal metastases from solid tumors: preliminary results from a phase I/II study (NCT 06462222)

jitc · abstract · 2025-11-04 · 2 matching annotations

91.2%

Guangzhou Medical University Affiliated Huizhou Hospital pemetrexed non-small cell lung cancer solid tumors small cell lung cancer Intrathecal PD-1 inhibitor breast cancer involved-field radiotherapy leptomeningeal metastases+1 more

… Institutional Review Board of the Affiliated Huizhou Hospital, Guangzhou Medical University, Huizhou, China (Approval number: 2024-KY-029-01). Informed con…